title: In vivo antimalarial action of a lipophilic iron (III) chelator: suppression of Plasmodium vinckei infection by reversed siderophore.
abstract: We assessed in vivo antimalarial action of a lipophilic iron (III) chelator belonging to a new synthetic family of biomimetic siderophores previously termed reversed siderophores (RSFs). The family member, RSF ileum2, was chosen for its high membrane permeability and fast irreversible inhibition of human malaria parasite growth in vitro. [Shanzer A, et al., Proc Natl Acad Sci USA 88:6585, 1991 and Lytton SD, et al., Blood 81:214, 1993]. The lipophilic drug was administered to Swiss mice by subcutaneous route in fractionated coconut oil at a dosage of 0.37 g/kg every 8 hr with no adverse reactions observed. After 3-4 injections demonstrable suppression of Plasmodium vinckei petteri infection was observed and an additional 3-4 injections resulted in 2-3-fold lower parasitemia with prolonged survival time over sham-injected control mice.
authors.affiliation: Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.
authors.forename: S D
authors.initials: SD
authors.lastname: Lytton
authors.forename: M
authors.initials: M
authors.lastname: Loyevsky
authors.forename: B
authors.initials: B
authors.lastname: Mester
authors.forename: J
authors.initials: J
authors.lastname: Libman
authors.forename: I
authors.initials: I
authors.lastname: Landau
authors.forename: A
authors.initials: A
authors.lastname: Shanzer
authors.forename: Z I
authors.initials: ZI
authors.lastname: Cabantchik
mesh_terms: D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D008288:Malaria / Q000188:drug therapy*; D051379:Mice; D017262:Siderophores / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D000962:Antimalarials; D007502:Iron Chelating Agents; D017262:Siderophores